BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15558216)

  • 1. Terrein: a new melanogenesis inhibitor and its mechanism.
    Park SH; Kim DS; Kim WG; Ryoo IJ; Lee DH; Huh CH; Youn SW; Yoo ID; Park KC
    Cell Mol Life Sci; 2004 Nov; 61(22):2878-85. PubMed ID: 15558216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term suppression of tyrosinase by terrein via tyrosinase degradation and its decreased expression.
    Park SH; Kim DS; Lee HK; Kwon SB; Lee S; Ryoo IJ; Kim WG; Yoo ID; Park KC
    Exp Dermatol; 2009 Jun; 18(6):562-6. PubMed ID: 19493001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hypopigmentary action of KI-063 (a new tyrosinase inhibitor) combined with terrein.
    Kim DS; Lee S; Lee HK; Park SH; Ryoo IJ; Yoo ID; Kwon SB; Baek KJ; Na JI; Park KC
    J Pharm Pharmacol; 2008 Mar; 60(3):343-8. PubMed ID: 18284814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine-1-phosphate decreases melanin synthesis via sustained ERK activation and subsequent MITF degradation.
    Kim DS; Hwang ES; Lee JE; Kim SY; Kwon SB; Park KC
    J Cell Sci; 2003 May; 116(Pt 9):1699-706. PubMed ID: 12665551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta1 decreases melanin synthesis via delayed extracellular signal-regulated kinase activation.
    Kim DS; Park SH; Park KC
    Int J Biochem Cell Biol; 2004 Aug; 36(8):1482-91. PubMed ID: 15147727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of 4-n-butylresorcinol on tyrosinase activity and melanin synthesis.
    Kim DS; Kim SY; Park SH; Choi YG; Kwon SB; Kim MK; Na JI; Youn SW; Park KC
    Biol Pharm Bull; 2005 Dec; 28(12):2216-9. PubMed ID: 16327152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partially purified components of Nardostachys chinensis suppress melanin synthesis through ERK and Akt signaling pathway with cAMP down-regulation in B16F10 cells.
    Jang JY; Kim HN; Kim YR; Choi WY; Choi YH; Shin HK; Choi BT
    J Ethnopharmacol; 2011 Oct; 137(3):1207-14. PubMed ID: 21816215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AVS-1357 inhibits melanogenesis via prolonged ERK activation.
    Kim DS; Lee HK; Park SH; Chae CH; Park KC
    Pharmazie; 2009 Aug; 64(8):532-7. PubMed ID: 19746843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geranylgeranylacetone inhibits melanin synthesis via ERK activation in Mel-Ab cells.
    Kim EH; Jeong HS; Yun HY; Baek KJ; Kwon NS; Park KC; Kim DS
    Life Sci; 2013 Aug; 93(5-6):226-32. PubMed ID: 23792203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acteoside inhibits melanogenesis in B16F10 cells through ERK activation and tyrosinase down-regulation.
    Son YO; Lee SA; Kim SS; Jang YS; Chun JC; Lee JC
    J Pharm Pharmacol; 2011 Oct; 63(10):1309-19. PubMed ID: 21899547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baicalein inhibits melanogenesis through activation of the ERK signaling pathway.
    Li X; Guo L; Sun Y; Zhou J; Gu Y; Li Y
    Int J Mol Med; 2010 Jun; 25(6):923-7. PubMed ID: 20428797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat treatment decreases melanin synthesis via protein phosphatase 2A inactivation.
    Kim DS; Park SH; Kwon SB; Youn SW; Park ES; Park KC
    Cell Signal; 2005 Aug; 17(8):1023-31. PubMed ID: 15894174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menadione (Vitamin K3) decreases melanin synthesis through ERK activation in Mel-Ab cells.
    Kim EH; Kim MK; Yun HY; Baek KJ; Kwon NS; Park KC; Kim DS
    Eur J Pharmacol; 2013 Oct; 718(1-3):299-304. PubMed ID: 24012927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMS 1001 inhibits melanin synthesis via ERK activation.
    Lee HE; Song J; Kim SY; Park KC; Min KH; Kim DS
    Pharmazie; 2013 Mar; 68(3):212-6. PubMed ID: 23556341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-melanogenesis effect of dehydroglyasperin C through the downregulation of MITF via the reduction of intracellular cAMP and acceleration of ERK activation in B16F1 melanoma cells.
    Lim JW; Ha JH; Jeong YJ; Park SN
    Pharmacol Rep; 2018 Oct; 70(5):930-935. PubMed ID: 30099299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-melanogenic activity of phytosphingosine via the modulation of the microphthalmia-associated transcription factor signaling pathway.
    Jang EJ; Shin Y; Park HJ; Kim D; Jung C; Hong JY; Kim S; Lee SK
    J Dermatol Sci; 2017 Jul; 87(1):19-28. PubMed ID: 28390782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phytol suppresses melanogenesis through proteasomal degradation of MITF via the ROS-ERK signaling pathway.
    Ko GA; Cho SK
    Chem Biol Interact; 2018 Apr; 286():132-140. PubMed ID: 29486182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lysophosphatidic acid on melanogenesis.
    Kim DS; Park SH; Kwon SB; Youn SW; Park KC
    Chem Phys Lipids; 2004 Feb; 127(2):199-206. PubMed ID: 14726002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partially purified Asiasari radix inhibits melanogenesis through extracellular signal-regulated kinase signaling in B16F10 cells.
    Jang JY; Lee JH; Shin HK; Choi YH; Lee JD; Choi BT
    Int J Mol Med; 2010 Feb; 25(2):287-92. PubMed ID: 20043140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of N,N,N-trimethyl phytosphingosine-iodide on melanogenesis via ERK activation-mediated MITF degradation.
    Lee WJ; Bang S; Chung BY; Jung H; Oh ES; Chang SE
    Biosci Biotechnol Biochem; 2016; 80(1):121-7. PubMed ID: 26263195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.